Clinical effect of eradication of helicobacter pylori in patients with idiopathic thrombocytopenic purpura
10.3760/cma.j.issn.1008-6706.2011.18.025
- VernacularTitle:抗幽门螺杆菌治疗用于特发性血小板减少性紫癜的疗效观察
- Author:
Jiru WANG
;
Xiaofei HONG
- Publication Type:Journal Article
- Keywords:
Helicobacter pylori;
Idiopathie thrombocytopenic purpur
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(18):2497-2499
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate clinical effect of eradication of helicobacter pylori in patients with idiopathic thrombocytopenic purpura(ITP). Methods145 cases with HP-positive ITP paitients were divided into two groups( platelet counts results < 50 × 109/L and platelet counts results > 50 × 109/L). 95 cases with platelet counts <50 × 109/L were divided into two groups and treated with prednisone and Hp eradication(48 cases) or with prednisone without Hp eradication(47 cases). 95 cases with platelet counts > 50 × 109/L were divided into two groups and treated with Hp eradication 25 cases)or follow-up without any treatment(25 cases). ResultsThe total effective rate in group treated with prednisone and Hp eradication was significantly higher than that in group with prednisone without Hp eradication( 92% vd 75%, x2 = 5.01 ,P < 0.05 ). The recurrence rate in two year in group treated with prednisone and Hp eradication was significantly lower than that in group with prednisone without Hp eradication( 19% vs 49%,x2 = 9. 69, P < 0. 01 ). HP eradicatiaon single can improve platelet counts in HP-positive ITP paitients.ConclusionThe detection and eradication of H pylori infection should be considered in patients with ITP. H. pylori eradication could be used for initial treatment in HP-positive ITP paitients.